A Genotype-Phenotype Urothelial Cancer Registry

Active, not recruitingOBSERVATIONAL
Enrollment

3,519

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Urothelial CancerRenal Pelvis CancerUreter CancerBladder Cancer
Interventions
OTHER

saliva sample and questionaire

"Urothelial Cancer Registry- Patients will complete a family history and urothelial cancer risk questionnaire, and will provide a buccal sample for germline DNA. If the cases have undergone germline sequencing as part of Protocol 12-245, they will not need to provide a buccal sample. If the cases have previously completed athe the Urothelial Baseline Questionnaire, in an MSKCC urology clinic they will not need to complete the urothelial cancer risk questionnaire."

OTHER

saliva sample, questionaire

Urothelial Cancer Registry- These participants will be requested to complete the risk factor questionnaire and to provide a saliva sample for DNA extraction.

Trial Locations (4)

10065

Memorial Sloan Kettering Cancer Center, New York

11553

Memorial Sloan Kettering Nassau, Uniondale

11725

Memorial Sloan Kettering Commack, Commack

07920

Memorial Sloan Kettering Basking Ridge, Basking Ridge

All Listed Sponsors
collaborator

University of Chicago

OTHER

collaborator

Fox Chase Cancer Center

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00902590 - A Genotype-Phenotype Urothelial Cancer Registry | Biotech Hunter | Biotech Hunter